Advantx Pharmaceuticals

Headquartered in New York and founded in 2022 by the Advantx Foundation, Advantx Pharmaceuticals Inc. is a biopharmaceutical company focused on bringing to market innovative therapies for central nervous system diseases based on Sigma receptors, unique ligand-operated chaperone proteins key regulators of the human body. REVOLUTIONIZING THE TREATMEN... T OF RARE AND CHRONIC CONDITIONS WITH INNOVATIVE SIGMA-TARGETED THERAPIES Unique Platform Targeting Sigma: Advantx Pharmaceuticals leads the global biotech industry with a proprietary Sigma platform of pharmaceutical-grade compounds that selectively target and modulate the ligand-operated chaperone proteins encoded by the SIGMAR1 and SIGMAR2 genes. Unlocking the Potential of Sigma Proteins: Sigma proteins, a unique evolutionary isolate distinct from any other human proteins, represent the pinnacle of protein evolution. As the unique ligand-operated chaperone receptor proteins, they play a crucial role in the intricate workings of the company's complex life systems. Unraveling the Complexity of human diseases: Advantx Pharmaceuticals has taken the forefront in unraveling the complex nature of human diseases, delving into the intricate details of Sigma proteins and harnessing their immense potential in addressing a wide range of degenerative, life-threatening, and incurable conditions. Advantxs Unique Approach: By precisely modulating Sigma proteins, the company's innovative therapies target multiple disease-causing pathways while normalizing the homeostasis of key proteins and cells under stress or DNA damage, and regulating key transcription factors. This genomic precision enables the company to positively modify the course of various conditions while minimizing undesirable side effects. Groundbreaking clinical progress: With an accelerated biomarker-based clinical development approach, the company brings the company's therapies to patients swiftly, safely, and effectively. The company's robust patent portfolio secures worldwide rights to the company's products ...Read More